159 related articles for article (PubMed ID: 36154921)
1. Exploring the relationship between autophagy and Gefitinib resistance in NSCLC by silencing PDLIM5 using ultrasound-targeted microbubble destruction technology.
Zhang Y; Lv W; Li H; Dong T; Wu H; Su C; Shu H; Nie F
Cancer Cell Int; 2022 Sep; 22(1):293. PubMed ID: 36154921
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound-mediated mesoporous silica nanoparticles loaded with PDLIM5 siRNA inhibit gefitinib resistance in NSCLC cells by attenuating EMT.
Wu H; Lv WH; Zhu YY; Jia YY; Nie F
Eur J Pharm Sci; 2023 Mar; 182():106372. PubMed ID: 36621614
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound-sensitive siRNA-loaded nanobubbles fabrication and antagonism in drug resistance for NSCLC.
Su C; Ren X; Yang F; Li B; Wu H; Li H; Nie F
Drug Deliv; 2022 Dec; 29(1):99-110. PubMed ID: 34964410
[TBL] [Abstract][Full Text] [Related]
4. Apatinib preferentially inhibits PC9 gefitinib-resistant cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway.
Song YA; Ma T; Zhang XY; Cheng XS; Olajuyin AM; Sun ZF; Zhang XJ
Cancer Cell Int; 2019; 19():117. PubMed ID: 31073278
[TBL] [Abstract][Full Text] [Related]
5. HMGB1-mediated autophagy promotes gefitinib resistance in human non-small cell lung cancer.
Lei T; Huang J; Xie F; Gu J; Cheng Z; Wang Z
Acta Biochim Biophys Sin (Shanghai); 2022 Mar; 54(4):fpage-lpage. PubMed ID: 35462475
[TBL] [Abstract][Full Text] [Related]
6. Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab.
Chen G; Kronenberger P; Teugels E; Umelo IA; De Grève J
BMC Med; 2012 Mar; 10():28. PubMed ID: 22436374
[TBL] [Abstract][Full Text] [Related]
7. Curcumin overcome primary gefitinib resistance in non-small-cell lung cancer cells through inducing autophagy-related cell death.
Chen P; Huang HP; Wang Y; Jin J; Long WG; Chen K; Zhao XH; Chen CG; Li J
J Exp Clin Cancer Res; 2019 Jun; 38(1):254. PubMed ID: 31196210
[TBL] [Abstract][Full Text] [Related]
8. PPARgamma agonists sensitize PTEN-deficient resistant lung cancer cells to EGFR tyrosine kinase inhibitors by inducing autophagy.
To KKW; Wu WKK; Loong HHF
Eur J Pharmacol; 2018 Mar; 823():19-26. PubMed ID: 29378193
[TBL] [Abstract][Full Text] [Related]
9. Novel cell-penetrating peptide-loaded nanobubbles synergized with ultrasound irradiation enhance EGFR siRNA delivery for triple negative Breast cancer therapy.
Jing H; Cheng W; Li S; Wu B; Leng X; Xu S; Tian J
Colloids Surf B Biointerfaces; 2016 Oct; 146():387-95. PubMed ID: 27388967
[TBL] [Abstract][Full Text] [Related]
10. miR-138-5p reverses gefitinib resistance in non-small cell lung cancer cells via negatively regulating G protein-coupled receptor 124.
Gao Y; Fan X; Li W; Ping W; Deng Y; Fu X
Biochem Biophys Res Commun; 2014 Mar; 446(1):179-86. PubMed ID: 24582749
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome Profiling of Acquired Gefitinib Resistant Lung Cancer Cells Reveals Dramatically Changed Transcription Programs and New Treatment Targets.
Wei N; Song Y; Zhang F; Sun Z; Zhang X
Front Oncol; 2020; 10():1424. PubMed ID: 32923394
[No Abstract] [Full Text] [Related]
12. MicroRNA‑506‑3p reverses gefitinib resistance in non‑small cell lung cancer by targeting Yes‑associated protein 1.
Zhu J; Tao L; Jin L
Mol Med Rep; 2019 Feb; 19(2):1331-1339. PubMed ID: 30535506
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound-targeted microbubble destruction to deliver siRNA cancer therapy.
Carson AR; McTiernan CF; Lavery L; Grata M; Leng X; Wang J; Chen X; Villanueva FS
Cancer Res; 2012 Dec; 72(23):6191-9. PubMed ID: 23010078
[TBL] [Abstract][Full Text] [Related]
14. Repurposing loperamide to overcome gefitinib resistance by triggering apoptosis independent of autophagy induction in KRAS mutant NSCLC cells.
Tong CWS; Wu MMX; Yan VW; Cho WCS; To KKW
Cancer Treat Res Commun; 2020; 25():100229. PubMed ID: 33152554
[TBL] [Abstract][Full Text] [Related]
15. MiR-181a contributes gefitinib resistance in non-small cell lung cancer cells by targeting GAS7.
Ping W; Gao Y; Fan X; Li W; Deng Y; Fu X
Biochem Biophys Res Commun; 2018 Jan; 495(4):2482-2489. PubMed ID: 29269300
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound-targeted microbubble destruction mediated miR-492 inhibitor suppresses the tumorigenesis in non-small cell lung cancer.
Zou W; Wang Y; Song Q; Li Q; Ren J; Liu X; Cui W
Ann Med; 2021 Dec; 53(1):2246-2255. PubMed ID: 34818961
[TBL] [Abstract][Full Text] [Related]
17. EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
Gong H; Li Y; Yuan Y; Li W; Zhang H; Zhang Z; Shi R; Liu M; Liu C; Chen C; Liu H; Chen J
BMC Cancer; 2020 Dec; 20(1):1189. PubMed ID: 33276757
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of autophagy by YC-1 promotes gefitinib induced apoptosis by targeting FOXO1 in gefitinib-resistant NSCLC cells.
Hu H; Zhang XW; Li L; Hu MN; Hu WQ; Zhang JY; Miao XK; Yang WL; Mou LY
Eur J Pharmacol; 2021 Oct; 908():174346. PubMed ID: 34270985
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound-triggered microbubble destruction enhances the radiosensitivity of glioblastoma by inhibiting PGRMC1-mediated autophagy in vitro and in vivo.
He Y; Dong XH; Zhu Q; Xu YL; Chen ML; Liu Z
Mil Med Res; 2022 Feb; 9(1):9. PubMed ID: 35152910
[TBL] [Abstract][Full Text] [Related]
20. Altered splicing of ATG16-L1 mediates acquired resistance to tyrosine kinase inhibitors of EGFR by blocking autophagy in non-small cell lung cancer.
Hatat AS; Benoit-Pilven C; Pucciarelli A; de Fraipont F; Lamothe L; Perron P; Rey A; Levra MG; Toffart AC; Auboeuf D; Eymin B; Gazzeri S
Mol Oncol; 2022 Oct; 16(19):3490-3508. PubMed ID: 35593080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
